Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,542.00    -44.00 (-0.96%)
Bid:
4,546.00
Ask:
4,550.00
Spread: 4.00 (0.088%)
Market Cap: £16.55b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

21 Mar 2023 09:48

RNS Number : 7195T
Coca-Cola HBC AG
21 March 2023
 

FOR IMMEDIATE RELEASE

21 March 2023

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that on 17 March 2023, a deferred bonus award was granted to the Chief Executive Officer over shares of CHF 6.70 in the Company relating to a performance related annual bonus for 2022 under the terms of the Company's Management Incentive Plan (the "Deferred Shares"):

 PDMR

Position

Number of Deferred Shares granted

ZORAN BOGDANOVIC

CEO

18,941

 

The Notification of Dealing Form can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

ZORAN BOGDANOVIC

 

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF EXECUTIVE OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

SHARES

 

 

CH0198251305

b)

 

Nature of the transaction

 

 

GRANT OF DEFERRED SHARES UNDER THE MANAGEMENT INCENTIVE PLAN. THE NUMBER OF DEFERRED SHARES GRANTED IS EQUIVALENT TO 50 PER CENT OF THE ANNUAL BONUS AWARDED TO THE CHIEF EXECUTIVE OFFICER FOR THE 2022

FINANCIAL YEAR, CALCULATED ON THE BASIS OF THE CLOSING PRICE FOR THE DEFERRED SHARES ON THE DATE OF GRANT. THE DEFERRED SHARES WILL HAVE A VESTING PERIOD OF THREE YEARS FROM 31 DECEMBER 2022.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

21.18 GBP

18,941

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

21.18 GBP

18,941

401,170.38 GBP

e)

 

Date of the transaction

 

2023-03-17

f)

 

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBQCBKKFNB
Date   Source Headline
12th Oct 20218:40 amRNSCCH Commits to Net Zero Emissions by 2040
7th Oct 202110:44 amRNSCoca-Cola HBC completes Caffe Vergnano investment
1st Oct 20218:20 amRNSIssue of equity and total voting rights
28th Sep 20212:10 pmRNSPublication of a Prospectus
20th Sep 202111:40 amRNSDirector/PDMR Shareholding
17th Sep 20212:23 pmRNS2021 Performance Share Plan
3rd Sep 20214:05 pmRNSDirector/PDMR Shareholding
1st Sep 202111:25 amRNSDirector/PDMR Shareholding
1st Sep 202110:59 amRNSIssue of equity and total voting rights
27th Aug 20218:47 amRNSDirector/PDMR Shareholding
24th Aug 202110:09 amRNSDirector/PDMR Shareholding
18th Aug 202111:48 amRNSDirector/PDMR Shareholding
18th Aug 20219:34 amRNSDirector/PDMR Shareholding
18th Aug 20219:11 amRNSDirector/PDMR Shareholding
17th Aug 20219:15 amRNSDirector/PDMR Shareholding
12th Aug 20219:00 amRNSAcquires Coca-Cola Bottling Company of Egypt
12th Aug 20217:00 amRNSStrong momentum across all segments
10th Aug 202112:04 pmRNSDirector/PDMR Shareholding
2nd Aug 202110:20 amRNSIssue of equity and total voting rights
19th Jul 20212:44 pmRNSDirector/PDMR Shareholding
9th Jul 20213:47 pmRNSNotice of Results
1st Jul 202110:52 amRNSIssue of equity and total voting rights
28th Jun 20217:00 amRNSCCH takes minority stake in Caffè Vergnano
22nd Jun 20211:55 pmRNSComposition of the Committees of the BoD
22nd Jun 20211:19 pmRNSResult of AGM
18th Jun 20212:02 pmRNSDirector/PDMR Shareholding
10th Jun 202111:57 amRNSAthens Exchange trading date of ordinary shares
1st Jun 202111:01 amRNSIssue of equity and total voting rights
21st May 20217:00 amRNSNotice of AGM
18th May 20211:50 pmRNSDirector/PDMR Shareholding
12th May 20217:00 amRNSGood start in a challenging environment
4th May 202110:12 amRNSBlock listing Interim Review
4th May 202110:05 amRNSTotal voting rights
19th Apr 20214:34 pmRNSDirector/PDMR Shareholding
19th Apr 202112:05 pmRNSNotice of Results
1st Apr 20214:09 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:03 pmRNSElection of Home Member State
18th Mar 20215:12 pmRNSDirector/PDMR Shareholding
18th Mar 20212:26 pmRNS2020 integrated annual report 'Adapt to Win'
18th Mar 202112:52 pmRNSDirector/PDMR Shareholding
18th Mar 202112:27 pmRNSDirector/PDMR Shareholding
18th Mar 20219:50 amRNSDirector/PDMR Shareholding
1st Mar 20218:33 amRNSIssue of Equity
18th Feb 202112:14 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSOperational agility delivers resilient performance
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.